MedLife S.A.

M&A Activity • Jul 15, 2022

No. 37/14.07.2022

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

In accordance with Law no. 24/2017 on issuers of financial instruments and market operations (republished) and ASF Rule no. 5/2018 on issuers of financial instruments and market operations

Report Date: 14 July 2022

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 33,217,623 RON

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

Signing of the Sale-Purchase Agreement with respect to the shares issued by Muntenia Medical Competences S.A. on July 14, 2022

The company informs the shareholders and investors regarding the signing of the Sale-Purchase Agreement with respect to the transfer of 1,882,496 shares issued by Muntenia Medical Competences S.A., representing 99.76% of the share capital of Muntenia Medical Competences S.A.

The Sale-Purchase Agreement of shares issued by Muntenia Medical Competences S.A. was concluded between Societatea de Investitii Financiare Muntenia S.A., as Seller, through its administrator SAI Muntenia Invest SA, and Vita Care Flav S.R.L., as Buyer, part of MedLife group.

The transfer of ownership of the shares held by SIF Muntenia SA in Muntenia Medical Competences S.A. is to be made no later than 30.09.2022 (with the possibility of extension), after the fulfillment by both parties of some conditions precedent to Closing, including the approval by the Competition Council.

We will inform shareholders and investors about the status of the transaction and completion of the transaction.

Mihail Marcu Chief Executive Officer

__________________